Altria Group, Inc.
MONYSECigarettesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/304% above fair value
$77.17−0.86 (-1.10%)
Close on Nov 2, 2026Market cap $128.85BP/E 15.9Yield 5.39%
Altria Oral Tobacco Products by Quarter
Oral Tobacco Products — Reported OCI Margin (% of Revenues Net of Excise Taxes) (%)
Altria Oral Tobacco Products: 65.1% in Q3 2026, down 3.9 pts from a year earlier.
Latest, Q3 2026
65.1%
Period ended Sep 30, 2026
Change on a year earlier
-3.9 pts
69.0% in Q3 2025
History
14 quarters
Since Q2 2023
Sources
10
Documents cited below
Where the Q3 2026 figure comes from
“|| Reported OCI margins 1 | 65.1 | % | 69.0 | % | (3.9) pp | 62.4 | % | 68.7 | % | (6.3) pp”
Source: Altria Earnings Release (Form 8-K Item 2.02 EX-99.1) (0000764180-26-000112), filed 2026-10-29 ↗
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Altria Oral Tobacco Products (%), quarterly Q2 2023–Q3 2026 [Data set]. Compiled from Altria SEC filings and investor materials. https://stockdatahq.com/stocks/mo/kpis/oral-rep-oci-margin
See every metric in the Altria KPI table. Data updated Nov 2, 2026.